Study of the effectiveness and safety of LigaSure™ in hysterectomy

Completed

• Conditions: Transvaginal hysterectomy; Urological and Genital Diseases

• Registration Number: ISRCTN13646289
• Lead Sponsor: Covidien Private Limited

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-12-21
• Last Update Posted: 6 February 2017

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 72

Inclusion Criteria

1. Female patients 35 years of age or older
2. Scheduled to undergo a transvaginal NOTES hysterectomy
3. Willing to provide informed consent

Exclusion Criteria

1. Multiple abdominal surgery, except caesarean section
2. History of coagulation disorder
3. History of liver and renal dysfunction within 6 months prior to inclusion into the study
4. Severe inflammatory diseases
5. Malignancy
6. Electrosurgery contraindicated
7. Hypersensitivity to or unable to tolerate general anesthesia or analgesic
8. Those participating any clinical trials within 3 months prior to the intervention
9. Not suitable for surgical intervention at the discretion of the investigator

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Operative time is measured as the duration from the time of skin incision to the time of final suture in skin closure during surgery.